PMS
PMS
Memos
Portfolio Login
Dashboard (Video)
Advisory
Blog
Contact Us
Login
Facebook
Twitter
Category:
Indian Markets
Memo – Risk, Benchmarking & Taxation
Indian Markets
,
Investing Framework
,
PMS
September 5, 2024
Exiting Suven Pharma with 663% Return in 4.5 years!
Indian Markets
,
Investing Framework
,
Stocks
August 9, 2024
Nifty@21,700: What should be the Portfolio Strategy for 2024?
Indian Markets
,
Investing Framework
,
Stocks
January 6, 2024
[Investor Memo] Wise to Optimise Expectations & Review Asset Allocation
Indian Markets
,
Investing Framework
May 4, 2022
Tenets of Commodity Investing – Framework, Experience & Learnings
Indian Markets
,
Industries
,
Investing Framework
,
Stocks
January 19, 2022
Is Real Estate the next Pharma?
Business Models
,
Indian Markets
,
Industries
,
Scuttlebutt
September 1, 2020
Memo: Let’s Brace for P&L Accidents But Not Overestimate Impact on Intrinsic Values
Indian Markets
,
Investing wisdom
,
Stocks
May 29, 2020
Financial & Mental Preparedness For What Lies Ahead
Food for thought
,
Indian Markets
,
Memo
March 26, 2020
10 reasons why long-term investors shun real estate stocks, and why its time to do the opposite
Business Models
,
Indian Markets
,
Industries
,
Investing Framework
,
MoneyControl Column
November 20, 2019
Only 2.5% of 8,000 Listed Indian Stocks Are Investable; Here’s The List
Indian Markets
,
Investing Framework
October 23, 2019
1
2
3
Next Page